Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses:
Research and development	$ 10,944	$ 9,286
General and administrative	4,934	3,762
Total operating expenses	15,878	13,048
Operating Income (Loss), Total	(15,878)	(13,048)
Interest income	108	54
Interest Expense	(254)
Net loss	$ (16,024)	$ (12,994)
Net loss per common share, basic and diluted	$ (0.26)	$ (0.25)
Weighted-average shares used to compute net loss per common share, basic and diluted	60,630,389	51,058,039